| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $172.7M | -1.6% |
| SG&A Expense | $54.6M | +33.2% |
| Operating Income | -$227.3M | -5.0% |
| Pre-tax Income | -$237.6M | -44.4% |
| Income Tax | -$469K | -57.9% |
| Net Income | -$236.8M | -49.2% |
| EPS (Basic) | -$4.48 | -20.4% |
| EPS (Diluted) | -$4.48 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.1M | -27.9% |
| Current Assets | $451.9M | +28.8% |
| Total Assets | $539.3M | +18.7% |
| Current Liabilities | $56.6M | +28.9% |
| Total Liabilities | $105.3M | +17.0% |
| Stockholders' Equity | $434.0M | +19.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.8M | -6.3% |
| Capital Expenditures | $2.5M | -58.3% |
| Investing Cash Flow | -$114.2M | -530.3% |
| Financing Cash Flow | $261.0M | +46.2% |
| Free Cash Flow | -$166.3M | -3.8% |